110286-57-2

Basic information

• Product Name: 1,8-Naphthyridine-3-carboxylic acid, 7-chloro-1-[(2,4-dimethoxyphenyl)methyl]-6-fluoro-1,4-dihydro-4-oxo-, ethyl ester
• CAS NO: 110286-57-2
• Molecular Formula: C20H18ClFN2O5
• Molecular Weight: 420.825
• Mol File: 110286-57-2.mol

Chemical Properties

• CAS DataBase Reference: 1,8-Naphthyridine-3-carboxylic acid, 7-chloro-1-[(2,4-dimethoxyphenyl)methyl]-6-fluoro-1,4-dihydro-4-oxo-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1,8-Naphthyridine-3-carboxylic acid, 7-chloro-1-[(2,4-dimethoxyphenyl)methyl]-6-fluoro-1,4-dihydro-4-oxo-, ethyl ester(110286-57-2)
• EPA Substance Registry System: 1,8-Naphthyridine-3-carboxylic acid, 7-chloro-1-[(2,4-dimethoxyphenyl)methyl]-6-fluoro-1,4-dihydro-4-oxo-, ethyl ester(110286-57-2)

Safety Data

• Hazardous Substances Data: 110286-57-2(Hazardous Substances Data)

Upstream product

• 20781-20-8 2,4-Dimethoxybenzylamine 
• 96568-05-7 2,6-dichloro-α-(ethoxymethylene)-5-fluoro-β-oxo-3-pyridinepropanoic acid ethyl ester 
• 96568-04-6 ethyl 3-(2,6-dichloro-5-fluoropyridin-3-yl)-3-oxopropanoate 
• 122-51-0 orthoformic acid triethyl ester 
• 110286-39-0 (Z)-2-(2,6-Dichloro-5-fluoro-pyridine-3-carbonyl)-3-(2,4-dimethoxy-benzylamino)-acrylic acid ethyl ester 

Downstream Products

• 635309-38-5 1-(2,4-dimethoxybenzyl)-6-fluoro-4-oxo-7-(pyrrolidin-1-yl)-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid ethyl ester 
• 908340-16-9 1-(2,4-dimethoxybenzyl)-6-fluoro-7-[(2-hydroxyethyl)methylamino]-4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid ethyl ester 
• 908340-49-8 1-(2,4-dimethoxybenzyl)-6-fluoro-4-oxo-7-[(S)-2-phenylaminomethylpyrrolidin-1-yl]-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid ethyl ester 
• 908340-14-7 1-(2,4-dimethoxy-benzyl)-6-fluoro-7-(2-hydroxymethyl-piperidin-1-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid ethyl ester 
• 908339-90-2 1-(2,4-dimethoxybenzyl)-6-fluoro-7-[(S)-2-hydroxymethylpyrrolidin-1-yl]-4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid ethyl ester 
• 908340-18-1 1-(2,4-dimethoxybenzyl)-7-[ethyl-(2-hydroxyethyl)amino]-6-fluoro-4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid ethyl ester 
• 908340-07-8 1-(2,4-dimethoxybenzyl)-6-fluoro-7-[(R)-2-hydroxymethylpyrrolidin-1-yl]-4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid ethyl ester 
• 635309-36-3 ethyl 7-(3-((tert-butoxycarbonyl)amino)pyrrolidin-1-yl)-1-(2,4-dimethoxybenzyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate 
• 1056598-36-7 methyl 1-(2,4-dimethoxybenzyl)-6-fluoro-7-((2S,4R)-4-hydroxy-2-(hydroxymethyl)pyrrolidinyl)-4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxylate 
• 635309-48-7 ethyl 7-((3S)-3-((tert-butoxycarbonyl)amino)pyrrolidin-1-yl)-1-(2,4-dimethoxybenzyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate 

Relevant articles and documents

Antibacterial compounds

Bacterial protein synthesis-inhibiting compounds having formula (I) and salts, prodrugs, and salts of prodrugs thereof, processes for making the compounds and intermediates in the processes, compositions containing the compounds, and methods of using the

Novel antibacterial class: A series of tetracyclic derivatives

We describe the synthesis and antibacterial activity of a series of tetracyclic naphthyridones. The members of this series act primarily via inhibition of bacterial translation and belong to the class of novel ribosome inhibitors (NRIs). In this paper we

Antibacterial compounds

Bacterial protein synthesis-inhibiting compounds having formula (I) and salts, prodrugs, salts of prodrugs, and metabolites thereof, processes for making the compounds and intermediates in the processes, compositions containing the compounds, and methods

Novel inhibitors of bacterial protein synthesis: Structure-activity relationships for 1,8-naphthyridine derivatives incorporating position 3 and 4 variants

Structure-activity relationships for a recently discovered novel ribosome inhibitor (NRI) class of antibacterials were investigated. Preliminary efforts to optimize protein synthesis inhibitory activity of the series through modification of positions 3 an

Rearrangements encountered in the attempted syntheses of pyridoazepinone carboxylic acids

(Chemical equation presented) Attempts to synthesize pyridoazepinone carboxylic acids such as 33 by standard methodologies resulted exclusively in unusual and unexpected rearrangement products. Seven-membered ring formation was attempted by ring expansion

Antibacterial compounds

Antibacterials having formula (I) and salts, prodrugs, and salts of prodrugs thereof, processes for making the compounds and intermediates used in the processes, compositions containing the compounds, and methods of prophylaxis and treatment of bacterial infections using the compounds are disclosed.